HLA (human leukocyte antigen)

In one sentence

HLA molecules display protein fragments for T-cell recognition.

The intuition

A display case is a useful analogy: the cell exposes a small sample of its proteins. The case and the fragment both matter. A T-cell receptor recognizes a peptide together with a particular HLA molecule, rather than simply recognizing any version of the original protein.

How it works

HLA is the human major histocompatibility complex (MHC). Class I molecules generally display peptides to CD8 T cells; class II molecules generally display peptides to CD4 T cells. The pathways and cell types differ, with important exceptions such as cross-presentation.

HLA alleles are shared across people. A person inherits a combination; it is not necessarily unique. HLA typing identifies that combination. Binding predictors estimate whether a candidate peptide can fit a specified allele’s groove. Processing, transport, loading and cell-surface expression still determine whether it is actually displayed.

Most conventional class I complexes require beta-2 microglobulin (B2M). Tumors can lose a presenting allele, alter processing or reduce expression. Allele-specific loss is different from complete loss of conventional class I display. Targets using retained alleles may remain possible.

HLA-C has lower surface expression than HLA-A/B in many contexts. Its smaller observed peptide share is not evidence that it is universally more permissive. Dataset representation and allele-specific prediction quality also matter. A measured peptide in a mixed tissue preparation does not establish its source cell or a safe tumor-specific T-cell response.

Why it matters in cancer

It connects antigen display to receptor recognition and explains why loss of a presenting allele can affect a treatment route.

Worked example

A mutation produces a plausible peptide for HLA-A*02:01. If the tumor loses the allele used by the intended receptor, binding predictions from inherited typing alone may no longer describe tumor presentation. Retained-allele assessment answers a different question from typing.

Common confusions

The HLA groove holds the peptide; the T-cell receptor (TCR) contacts the peptide–HLA complex.
Binding prediction is not measured presentation or T-cell recognition.
A surface-antigen engager can bypass HLA; a TCR-based engager cannot.

TCR sequencing and case assessment.

Sources and scope

General teaching, source-checked October 8, 2026. The examples are hypothetical unless a study is explicitly named. Expert and learner review remain pending.